| SECTOR | INDUSTRY |
| Health Care | Biotechnology |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
| Share Statistics | MTNB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1.9 | $252.6 | 1% |
|
| Shares Out (Mil) | 6.4 | 52.3 | 16% |
|
| Institutional Ownership | 35.7% | 92.1% | 15% |
|
| Float (Mil) | 4.2 | 40.2 | 10% |
|
| Beta | 1.68 | 0.95 | 87% |
|
| Avg Daily Volume (000s) | 29,268 | 455 | 99% |
|
| Price Change (52-week) |
(65.0%) | 52.9% | 11% |
|
| Growth | MTNB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | 14.4% | (9.9%) | 62% |
|
| EPS (5yr) | 19.4% | 16.0% | 67 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 25.1% | (15.6%) | 83% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | MTNB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $38 | na |
|
| Net Income (TTM) (Mil) | ($11) | ($43) | 29% |
|
| EPS (TTM) | ($1.935) | ($1.600) | 15% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | ($31) | 23% |
|
| Net Cash Flow (TTM) (Mil) | na | $5 | na |
|
| Long-Term Debt (Q1) (Mil) | $1 | $5 | 15% |
|
| Enterprise Value (Q1) (Mil) | $3 | $180 | 4% |
|
| Valuation | MTNB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.63 | 2.56 | 12% |
|
| P/E | na | 19.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | MTNB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 63.8% | na |
|
| Net Margin | na | (67.3%) | na |
|
| ROA | (118.5%) | (49.8%) | 5% |
|
| ROE | (228.4%) | (55.5%) | 4% |
|
| Liabilities to Assets | 48.6% | 30.3% | 40% |
|
| F-Score | 3 | 3 | 19% |
|
Matinas BioPharma Holdings, Inc. did not pass any screens on 7/31/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
